CPL207-280, a Potent and Safe GPR40 Agonist for the treatment of Type 2 Diabetes

被引：2
|
作者：
Bazydlo-Guzenda, Katarzyna
Buda, Pawel
Kozlowska, Izabela
Mach, Mateusz
Teska-Kaminska, Malgorzata
Stelmach, Filip
Wasinska-Kalwa, Malgorzata
Galazka, Kinga
Dubiel, Krzysztof K.
Pieczykolan, Jerzy S.
Wieczorek, Maciej
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2333-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2333-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus
    Hamdouchi, Chafiq
    Maiti, Pranab
    Warshawsky, Alan M.
    DeBaillie, Amy C.
    Otto, Keith A.
    Wilbur, Kelly L.
    Kahl, Steven D.
    Lewis, Anjana Patel
    Cardona, Guemalli R.
    Zink, Richard W.
    Chen, Keyue
    Siddaramaiah, C. R.
    Lineswala, Jayana P.
    Neathery, Grace L.
    Bouaichi, Cecilia
    Diseroad, Benjamin A.
    Campbell, Alison N.
    Sweetana, Stephanie A.
    Adams, Lisa A.
    Cabrera, Over
    Ma, Xiaosu
    Yumibe, Nathan P.
    Montrose-Rafizadeh, Chahrzad
    Chen, Yanyun
    Miller, Anne Reifel
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 934 - 945
  • [42] Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40
    Waring, Michael J.
    Baker, David J.
    Bennett, Stuart N. L.
    Dossetter, Alexander G.
    Garcia, Mark Fenwick Rob
    Georgsson, Jennie
    Groombridge, Sam D.
    Loxham, Susan
    MacFaul, Philip A.
    Maskill, Katie G.
    Morgan, David
    Morrell, Jenny
    Pointon, Helen
    Robb, Graeme R.
    Smith, David M.
    Stokes, Stephen
    Wilkinson, Gary
    MEDCHEMCOMM, 2015, 6 (06) : 1024 - 1029
  • [43] LY2881835: a potent, efficacious and selective GPR40 agonist stimulates insulin and GLP-1 secretion normalising glucose levels in preclinical models of type 2 diabetes
    Miller, A. Reifel
    Cox, A.
    Briere, D.
    Marcelo, M.
    Rani, S. S. N.
    Padmaja, R.
    Wilbur, K.
    Osborne, E.
    Zink, R.
    Jett, D.
    Montrose-Rafizadeh, C.
    Michael, M.
    Bokvist, K.
    Matti, P.
    Hamdouch, C.
    DIABETOLOGIA, 2012, 55 : S228 - S228
  • [44] Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes
    Yoon, Jongmin
    Lee, Don-Gil
    Song, Haengjin
    Hong, Dahae
    Park, Ji Soo
    Hong, Changhee
    An, Kyung Mi
    Lee, Jung Woo
    Park, Joon-Tae
    Yoon, Hongchul
    Tak, Jihoon
    Kim, Sang Geon
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [45] Safety and pharmacokinetic study of CPL207280, a novel GPR40 receptor agonist, after a multiple-dose in healthy volunteers
    Bazydlo-Guzenda, K.
    Jarus-Dziedzic, K.
    Gierczak-Pachulska, A.
    Bus-Kwasnik, K.
    Rudzki, P. J.
    Wieczorek, M.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 116 - 117
  • [46] Role of GPR40 in pathogenesis and treatment of Alzheimer's disease and type 2 diabetic dementia
    Chen, Jing-Jing
    Gong, Yu-Hang
    He, Ling
    JOURNAL OF DRUG TARGETING, 2019, 27 (04) : 347 - 354
  • [47] Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
    Brown, Sean P.
    Dransfield, Paul J.
    Vimolratana, Marc
    Jiao, XianYun
    Zhu, Liusheng
    Pattaropong, Vatee
    Sun, Ying
    Liu, Jinqian
    Luo, Jian
    Zhang, Jane
    Wong, Simon
    Zhuang, Run
    Guo, Qi
    Li, Frank
    Medina, Julio C.
    Swaminath, Gayathri
    Lin, Daniel C. -H.
    Houze, Jonathan B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (09): : 726 - 730
  • [48] Discovery of clinical candidate MR1704: A novel isothiazole based GPR40 agonist for diabetes
    Okochi, Munetaka
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [49] Pharmacokinetic/Pharmacodynamic Modeling of TAK-875, a Novel GPR40 Agonist, in Japanese Patients with Type 2 Diabetics
    Matsuno, Kumi
    Hirayama, Masashi
    Araki, Takahiro
    Hiroi, Shinzo
    Kaku, Kohei
    DIABETES, 2011, 60 : A616 - A616
  • [50] Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes
    Christiansen, Elisabeth
    Urban, Christian
    Merten, Nicole
    Liebscher, Kathrin
    Karlsen, Kasper K.
    Hamacher, Alexandra
    Spinrath, Andreas
    Bond, Andrew D.
    Drewke, Christel
    Ullrich, Susanne
    Kassack, Matthias U.
    Kostenis, Evi
    Ulven, Trond
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (22) : 7061 - 7064
12345